Form Type: 4

SEC EDGAR Link
Accession Number:0001181431-14-034525
Date:2014-10-16
Issuer: EXACT SCIENCES CORP (EXAS)
Original Submission Date:

Reporting Person:

CRAWFORD SALLY
C/O EXACT SCIENCES CORP.
441 CHARMANY DRIVE MADISON, WI 53719

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2014-10-16 M 5,000 a $2.24 217,341 direct
COMMON STOCK 2014-10-16 M 15,000 a $2.09 232,341 direct
COMMON STOCK 2014-10-16 M 7,768 a $3.00 240,109 direct
COMMON STOCK 2014-10-16 S 27,768 d $22.84 212,341 direct
COMMON STOCK 2014-10-17 M 7,232 a $3.00 219,573 direct
COMMON STOCK 2014-10-17 M 15,000 a $0.71 234,573 direct
COMMON STOCK 2014-10-17 M 5,536 a $3.43 240,109 direct
COMMON STOCK 2014-10-17 S 27,768 d $23.68 212,341 direct
COMMON STOCK 2014-10-20 M 2,131 a $3.43 214,472 direct
COMMON STOCK 2014-10-20 M 15,772 a $8.52 230,244 direct
COMMON STOCK 2014-10-20 M 5,257 a $8.52 235,501 direct
COMMON STOCK 2014-10-20 M 4,608 a $10.18 240,109 direct
COMMON STOCK 2014-10-20 S 27,768 d $23.93 212,341 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.24 2014-10-16 deemed execution date M 5,000 (d) 2006-07-22 2015-07-22 common stock 15,000 $2.24 0 direct
STOCK OPTION (RIGHT TO BUY) 2.09 2014-10-16 deemed execution date M 15,000 (d) 2007-07-21 2016-07-21 common stock 15,000 $2.09 0 direct
STOCK OPTION (RIGHT TO BUY) 3.0 2014-10-16 deemed execution date M 7,768 (d) 2008-08-10 2017-08-10 common stock 15,000 $3.00 7,232 direct
STOCK OPTION (RIGHT TO BUY) 3.0 2014-10-17 deemed execution date M 7,232 (d) 2008-08-10 2017-08-10 common stock 7,232 $3.00 0 direct
STOCK OPTION (RIGHT TO BUY) 0.71 2014-10-17 deemed execution date M 15,000 (d) 2009-07-18 2018-07-18 common stock 15,000 $0.71 0 direct
STOCK OPTION (RIGHT TO BUY) 3.43 2014-10-17 deemed execution date M 5,536 (d) 2011-07-16 2020-07-16 common stock 7,667 $3.43 2,131 direct
STOCK OPTION (RIGHT TO BUY 3.43 2014-10-20 deemed execution date M 2,131 (d) 2011-07-16 2020-07-16 common stock 2,131 $3.43 0 direct
STOCK OPTION (RIGHT TO BUY) 8.52 2014-10-20 deemed execution date M 15,772 (d) 2014-07-28 2021-07-28 common stock 15,772 $8.52 0 direct
STOCK OPTION (RIGHT TO BUY) 8.52 2014-10-20 deemed execution date M 5,257 (d) 2012-07-28 2021-07-28 common stock 5,257 $8.52 0 direct
STOCK OPTION (RIGHT TO BUY) 10.18 2014-10-20 deemed execution date M 4,608 (d) 2013-07-26 2022-07-26 common stock 4,608 $10.18 0 direct
Footnotes
IDfootnote
f1 the exercise of these options and the subsequent sale of common stock reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted september 8, 2014. the sales of shares pursuant to this 10b5-1 trading plan and disclosed on this form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. as a result, the 10b5-1 trading plan has been terminated effective as of the filing of this form 4.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. the reporting person undertakes to provide exact sciences corporation, any security holder of exact sciences corporation, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this form 4.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. the reporting person undertakes to provide exact sciences corporation, any security holder of exact sciences corporation, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this form 4.
f4 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. the reporting person undertakes to provide exact sciences corporation, any security holder of exact sciences corporation, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this form 4.
WhaleWisdom Logo

Elevate your investments